This protein is increased in the liver of rapamycin-treated mice, suggesting that the regulation of the endolysosomal system and the control of inflammatory pathways during aging is similar ...

Rapamycin is a naturally occurring compound primarily used to prevent organ rejection in transplant patients. It’s also considered a promising anti-aging drug among longevity seekers.

Tech entrepreneur and longevity advocate Bryan Johnson has discontinued his use of rapamycin, a controversial anti-ageing ...

The former Silicon Valley executive said preclinical and clinical research indicated that prolonged rapamycin use can disrupt ...

leading to research into its potential anti-aging benefits. Unfortunately for Johnson, it turns out that rapamycin was having the opposite effect to what he intended: the drug was actually aging him.

Bryan Johnson, a tech entrepreneur, has stopped using rapamycin, a drug not approved for anti-aging by the FDA, following concerns it may have aged him and caused infections. Johnson experienced ...

Believing in rapamycin’s potential as a “longevity ... and even envisioned “longevity clinics” where personalized anti-aging treatments could be provided. The review also highlights ...

He added: “Additionally, on October 27th, a new pre-print indicated that Rapamycin was one of a handful of supposed longevity interventions to cause an increase/acceleration of aging in humans ...

An curved arrow pointing right. Could one pill help us live longer? Scientists and investors are racing to find a drug to slow aging, trying things like metformin and rapamycin. But the ...